Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on visible light catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel visible-light method for beta-aminocarbonyls using oxalyl oxime esters. High yield, mild conditions. Cost-effective pharma intermediate manufacturing solution.
Patent CN119930443A details a visible light photocatalytic method for trifluoromethylation. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115838330B reveals a visible-light method for dicarboxylic acids using CO2. This breakthrough offers cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN109134326B details a mild, visible-light catalyzed synthesis of S-aryl thiosulfones using thiourea and metabisulfite, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Novel visible light method synthesizes 3-sulfonyl spirocyclic trienones using air oxidant. Reduces energy and metal waste for reliable pharmaceutical intermediate supply chains.
Patent CN113444005B details a green visible-light method for synthesizing glutaric acids from olefins and CO2, offering significant supply chain and cost advantages.
Novel photocatalytic route for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light. Offers mild conditions and broad substrate scope for pharma applications.
Patent CN110698360A details a green visible-light method for amide synthesis. Discover cost-effective, metal-free manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN103910723A reveals a novel visible light catalytic method for indoloquinoline synthesis using cheap metal salts and air oxygen, offering significant cost and supply chain advantages.
Patent CN113603653A reveals a visible light-promoted method for seleno-oxazolidine-2,4-dione. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable green chemistry.
Novel visible-light method replaces expensive silver reagents, offering high-yield, scalable production for pharmaceutical intermediates.
Patent CN106831603B reveals metal-free visible light synthesis for fluoropyrimidines, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN113773227A details a visible-light mediated method for epsilon-cyano carboxylic acids using CO2. Offers cost-effective pharma intermediate manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Patent CN112142796A details a mild synthesis of isoquinolinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel photoredox method for alpha,alpha-difluoro-beta-carbonyl sulfones using visible light, offering mild conditions and broad substrate scope for pharma intermediates.
Patent CN110818584B reveals a metal-free visible light method for synthesizing alpha,beta-unsaturated amides, offering cost reduction and scalable pharmaceutical intermediate manufacturing.
Novel green synthesis method for alpha-bromo-aromatic ketones using Ru(bpy)3Cl2 photocatalyst, offering high selectivity and mild conditions for pharmaceutical intermediates.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.